Culbertson A N & Co’s Eli Lilly LLY Stock Holding History

Culbertson A N & Co’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$809K	Hold	880	–	–	0.11%	101
2025 Q4	$946K	Hold	880	–	–	0.13%	94
2025 Q3	$671K	Buy	880 +4	+0.5%	+$2.98K	0.1%	101
2025 Q2	$683K	Buy	876 +123	+16%	+$95.6K	0.1%	101
2025 Q1	$622K	Buy	753 +441	+141%	+$367K	0.1%	103
2024 Q4	$241K	Sell	312 -72	-19%	-$59.6K	0.04%	123
2024 Q3	$340K	Sell	384 -5	-1%	-$4.5K	0.05%	114
2024 Q2	$352K	Sell	389 -14	-3%	-$11.2K	0.06%	110
2024 Q1	$314K	Hold	403	–	–	0.05%	111
2023 Q4	$235K	Hold	403	–	–	0.04%	117
2023 Q3	$216K	Buy	+403	New	+$208K	0.04%	114

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Culbertson A N & Co's LLY Position: Q1 2026 in Review

Culbertson A N & Co held its Eli Lilly (LLY) position steady in Q1 2026 at 880 shares worth $809K. The position accounts for 0.11% of the portfolio, ranked #101.

Culbertson A N & Co first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $946K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Culbertson A N & Co held 880 shares of Eli Lilly worth $809K as of Q1 2026.
Culbertson A N & Co left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.11% of Culbertson A N & Co's portfolio in Q1 2026, its #101 holding.
Culbertson A N & Co first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
Culbertson A N & Co's Eli Lilly position peaked at $946K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Culbertson A N & Co's 13F filing for Q1 2026, filed 12 May 2026.